Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 12-2020 | |
| Sales | 7,678 | 17,072 | 4,052 | 0 | 0 |
| Cost of Goods | 3,053 | 10,253 | 2,635 | N/A | N/A |
| Gross Profit | 4,625 | 6,819 | 1,418 | N/A | N/A |
| Operating Expenses | 17,991 | 70,071 | 17,825 | 0 | 0 |
| Operating Income | -13,313 | -62,999 | -15,773 | N/A | N/A |
| Interest Expense | 0 | 72 | 82 | 0 | 0 |
| Other Income | 470 | 14 | 380 | 0 | 0 |
| Pre-tax Income | -12,844 | -63,057 | -15,475 | 0 | 0 |
| Income Tax | -2,533 | -8,864 | -2,726 | N/A | N/A |
| Net Income Continuous | -10,310 | -54,193 | -12,749 | N/A | N/A |
| Net Income | $-10,310 | $-54,193 | $-12,749 | $N/A | $N/A |
| EPS Basic Total Ops | -0.35 | -1.83 | -0.43 | N/A | N/A |
| EPS Basic Continuous Ops | -0.34 | -1.83 | -0.43 | N/A | N/A |
| EPS Diluted Total Ops | -0.35 | -1.83 | -0.43 | N/A | N/A |
| EPS Diluted Continuous Ops | -0.34 | -1.83 | -0.43 | N/A | N/A |
| EBITDA(a) | $-13,162 | $-62,412 | $-15,660 | $N/A | $N/A |